Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Am J Med Genet C Semin Med Genet. 2017 May 30;175(2):268–278. doi: 10.1002/ajmg.c.31558

Table I.

Frequency of institutions classifying discrete diagnoses/phenotypes as DSD.

Diagnoses/Phenotypes Classified as DSD
n %
45,X/46,XY MGD, ovotestes 22 100
46,XX/46,XY chimera, ovotestes 22 100
Ovotestes 22 100
46,XX with male phenotype 22 100
Androgen biosynthesis defect (e.g., 5α reductase deficiency) 22 100
Androgen excess in 46,XX due to fetal (e.g., 21-hydroxylase deficiency), fetoplacental (e.g., aromatase deficiency), or maternal (e.g., luteoma) causes 22 100
Defect in androgen action (e.g., complete androgen insensitivity syndrome (CAIS); partial androgen insensitivity syndrome (PAIS)) 22 100
Complete gonadal dysgenesis 22 100
Partial gonadal dysgenesis 22 100
Disorders of AMH and AMH receptor (persistent Müllerian duct syndrome) 20   91
LH receptor defects (e.g., Leydig cell hypoplasia, aplasia) 17   81*
45,X Turner syndrome and variants 16 73
Proximal hypospadias with uni-/bilateral undescended teste(s) 14   70
47,XXY Klinefelter and variants 15 68
Gonadal regression (anorchia) 15 68
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome/Müllerian duct aplasia, renal aplasia, and cervicothoracic somite dysplasia (MURCS) 14   67*
46,XY bladder/cloacal anomalies 13   62*
46,XX bladder/cloacal anomalies 13   62*
Vaginal atresia 13 62
Isolated micropenis 12   57*
Proximal hypospadias with descended testes 10   50
Distal/mid-shaft hypospadias 6   30
Undescended teste(s) 6   27
Trauma 0     0
*

one site selected “prefer not to answer” and therefore was not included in calculations

two sites selected “prefer not to answer” and therefore were not included in calculations

Note: Diagnoses/Phenotypes are listed identically to how they were displayed on the survey. Abbreviations not included above are as follows: MGD = Mixed Gonadal Dysgenesis; AMH = Anti- Müllerian Hormone; LH = Luteinizing Hormone